MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cerebellar involvement in progressive supranuclear palsy and corticobasal degeneration

S. Jo, KW. Park, N. Choi, CS. Lee, MS. Kim (Seoul, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 914

Keywords: Cerebellum, Corticobasal degeneration (CBD), Progressive supranuclear palsy(PSP)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: To investigate cerebellar involvement in vivo in patients with corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) using [18F]FDG PET.

Background: Cerebellar ataxia is an exclusion criterion for CBD or PSP. However, cerebellar involvement in pathologically proven PSP cases has been reported. We investigated the frequency, clinical manifestations and diagnostic imaging of CBD or PSP with prominent cerebellar ataxia.

Method: Consecutive patients diagnosed with CBD or PSP between January 2009 and January 2019 were reviewed from atypical parkinsonism database. Clinical data were abstracted from medical records, mainly at the time of the diagnosis with neuroimaging. Patients who had cerebellar ataxia (either limb ataxia or gait ataxia) on the neurological examination, and who also had cerebellar hypometabolism in [18F]FDG-PET were evaluated. [18F]FDG-PET was analyzed by single-subject SPM analysis, followed by region-of-interest (ROI) based analysis. The regional glucose uptake in the cerebellum, which was expressed as z scores, was compared between PSP and CBD patients.

Results: Among 41 patients with clinically diagnosed PSP, 21 patients had cerebellar ataxia (PSP-C) on neurological examination. Among 27 patients with clinically diagnosed CBD, 10 patients showed cerebellar ataxia or were in bed-ridden state(CBD-C). Gait ataxia was more prominent than limb ataxia in patients with PSP-C and CBD-C. Ocular cerebellar signs, such as hypermetria or nystagmus, were not present in patients with PSP-C and CBD-C. Patients with PSP showed significant hypometabolism in the superior and anterior vermis, and anterior lobe of cerebellum when compared with patients with CBD(Figure1, error bar = 1 SEM).

Conclusion: Cerebellar involvement is present in some patients with PSP or CBD. In particular, patients with PSP-C exhibited hypometabolism of superior, anterior part of vermis, and anterior lobe of cerebellum in [18F]FDG-PET, which accounts for prominent gait ataxia in these patients.

Figure1 JSY

To cite this abstract in AMA style:

S. Jo, KW. Park, N. Choi, CS. Lee, MS. Kim. Cerebellar involvement in progressive supranuclear palsy and corticobasal degeneration [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cerebellar-involvement-in-progressive-supranuclear-palsy-and-corticobasal-degeneration/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cerebellar-involvement-in-progressive-supranuclear-palsy-and-corticobasal-degeneration/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley